Postnatal persistence of cardiac remodeling and dysfunction in late fetal growth restriction

Fatima Crispi1, Francesca Crovetto2, Mérida Rodriguez-López1,3

  • 1Barcelona Center for Maternal-Fetal and Neonatal Medicine (BCNatal), Center for Biomedical Research on Rare Diseases (CIBER-ER), Instituto Clínic de Ginecología, Obstetricia y Neonatología (ICGON), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic and Hospital Sant Joan de Deu, University of Barcelona, Barcelona, Spain.

Insights

Fetal growth restriction (FGR) impacts 7-10% of pregnancies, leading to heart remodeling in fetuses. This programming increases cardiovascular risk in adulthood, persisting from infancy through adolescence.

Area of Science:

  • Obstetrics
  • Cardiology
  • Developmental Biology

Background:

  • Fetal growth restriction (FGR) affects 7-10% of pregnancies.
  • FGR exposes fetuses to adverse in utero conditions, impacting development.
  • Growth-restricted fetuses exhibit cardiac remodeling and dysfunction.

Purpose of the Study:

  • To review cardiovascular programming in fetal growth restriction.
  • To examine postnatal consequences of FGR-induced cardiac changes.
  • To discuss strategies for mitigating cardiovascular risk in affected individuals.

Main Methods:

  • Literature review of current evidence.
  • Analysis of studies on fetal cardiac adaptations.
  • Synthesis of research on long-term cardiovascular outcomes.

Main Results:

  • Cardiac remodeling (systolic/diastolic dysfunction) is evident in FGR.
  • These changes are present in both early severe and late-onset FGR.
  • Cardiovascular alterations persist postnatally into adolescence and adulthood.

Conclusions:

  • Fetal growth restriction leads to persistent cardiovascular remodeling.
  • This programming increases susceptibility to adult cardiovascular disease.
  • Interventions may reduce the long-term cardiovascular risk associated with FGR.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
151
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
158
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K